Beijing Luzhu Biotechnology Co., Ltd. (HKG:2480)
Hong Kong
· Delayed Price · Currency is HKD 24.88
+0.02 (0.08%)
At close: Apr 29, 2026
HKG:2480 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -150.36 | -168.24 | -249.35 | -725.18 | -539.36 |
| Depreciation & Amortization | 30.89 | 25.01 | 16.11 | 9.88 | 6.54 |
| Other Amortization | 0.3 | - | - | 2.55 | 6.19 |
| Loss (Gain) From Sale of Assets | 0.01 | 0.25 | -0.06 | 0 | 0.01 |
| Asset Writedown & Restructuring Costs | 5.93 | - | - | - | - |
| Loss (Gain) From Sale of Investments | -3.26 | -11.1 | -11.38 | -13.87 | -10.8 |
| Loss (Gain) on Equity Investments | 0.01 | - | - | - | - |
| Stock-Based Compensation | - | 33.5 | 73.58 | 111.41 | 76.24 |
| Other Operating Activities | 0.76 | -8.43 | -17.14 | 539.76 | 440.03 |
| Change in Accounts Receivable | -1.94 | 34.94 | -23.83 | -14.38 | -4.28 |
| Change in Inventory | 2.09 | -2.26 | -0.94 | 2.79 | -5.24 |
| Change in Unearned Revenue | 2 | - | - | 0.76 | 17.04 |
| Change in Other Net Operating Assets | -15.47 | 10.24 | 23.05 | 9.01 | -5.53 |
| Operating Cash Flow | -129.05 | -86.09 | -189.95 | -77.27 | -19.17 |
| Capital Expenditures | -60.13 | -94.37 | -85.78 | -208.21 | -59.92 |
| Sale of Property, Plant & Equipment | 0 | - | 0.11 | - | - |
| Sale (Purchase) of Intangibles | -1.22 | -4.02 | - | -3.57 | - |
| Investment in Securities | -64.14 | 47.89 | 173.7 | 33.57 | -343.24 |
| Other Investing Activities | 0.83 | 2.92 | 10.56 | -45.05 | -0.84 |
| Investing Cash Flow | -124.65 | -47.58 | 98.58 | -223.26 | -404 |
| Long-Term Debt Issued | 204.52 | 54.86 | 10 | 338 | 450 |
| Long-Term Debt Repaid | - | -7 | -3.06 | -0.52 | - |
| Net Debt Issued (Repaid) | 204.52 | 47.86 | 6.94 | 337.48 | 450 |
| Issuance of Common Stock | - | - | 300.18 | 8.7 | 12.31 |
| Repurchase of Common Stock | -43.12 | -32.31 | - | - | - |
| Other Financing Activities | -6.1 | -0.66 | -33.95 | -9.2 | -7.32 |
| Financing Cash Flow | 155.3 | 14.89 | 273.17 | 336.98 | 454.99 |
| Foreign Exchange Rate Adjustments | -1.54 | 1.01 | 7.11 | 0.5 | - |
| Net Cash Flow | -99.94 | -117.77 | 188.92 | 36.95 | 31.83 |
| Free Cash Flow | -189.17 | -180.45 | -275.72 | -285.47 | -79.08 |
| Free Cash Flow Per Share | -0.95 | -0.89 | -1.39 | -1.96 | -0.87 |
| Cash Interest Paid | 6.1 | 0.66 | 0.17 | 0.06 | - |
| Levered Free Cash Flow | -145.4 | -164.47 | -157.51 | -139.9 | - |
| Unlevered Free Cash Flow | -141.29 | -163.99 | -156.98 | -142 | - |
| Change in Working Capital | -13.33 | 42.92 | -1.72 | -1.82 | 1.98 |
Source: S&P Capital IQ. Standard template. Financial Sources.